Effect of erythropoietin (EPO) on cognitive function and frontal lobe activity in patients with Bipolarity and unipolar depression in remission (PRETEC-EPO)
This historical record does not confirm current site availability.
Understand this study
What did researchers investigate?
This EU register entry describes an interventional medicine trial, designed to assign participants a study treatment. The protocol sets out the treatment, eligibility criteria and assessments. Check the source details below for country statuses and any transfer to CTIS.
Who was this study for?
This study was for people with bipolarity. Other eligibility criteria applied.
- Listed locations
- Denmark
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Study information
- Recruitment status
- Completed
- Enrollment listed in the registry
- 75
- Sponsor
- Copenhagen Affective Disorder research Center (CADIC), Psychiatric Centre Copenhagen, Rigshospitalet
- Sponsor type
- Research institute
- Study type
- Biological
- Intervention type
- BIOLOGICAL
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- Denmark
- Age range
- Not clearly listed
- Official registry ID
- EUCTR 2016-004023-24
- Official title
Show the full official title
Effect of erythropoietin (EPO) on cognitive function and frontal lobe activity in patients with bipolar disorder and unipolar depression in remission (PRETEC-EPO)
Get this study by email
Recruitment & locations
CompletedDenmark
Registry details
- Denmark — Completed
Questions about this study
Who is behind this study?
The study sponsor is Copenhagen Affective Disorder research Center (CADIC), Psychiatric Centre Copenhagen, Rigshospitalet, a research institute.
Who was this study for?
This study was for people with bipolarity. Other eligibility criteria applied.
